Routine

Motor neurone disease (ALS)

Neurology · Neurology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

A progressive neurodegenerative disease of upper and lower motor neurones causing weakness, wasting and bulbar failure with preserved sensation. Care is multidisciplinary and anticipatory — protecting breathing, swallowing and communication — with riluzole to modestly slow progression. First action: refer to a specialist neuromuscular/MND service.

Red flags

  • Refer promptly to a neuromuscular/MND specialist service for diagnosis and coordinated care
  • Involve respiratory and palliative teams early
  • Admit for acute respiratory decompensation, aspiration or feeding crises — within the agreed ceiling of care

Assessment

Investigations

  • Primarily clinical
  • EMG/nerve conduction studies show widespread denervation with normal sensory studies
  • MRI brain/spine to exclude mimics (cord compression, MS)
  • Bloods to exclude treatable causes; genetic testing where indicated
  • Baseline and serial respiratory function (FVC, SNIP)

Management

  • Specialist MDT care
  • Riluzole modestly prolongs survival; consider other approved disease- modifying agents where available
  • Non-invasive ventilation improves survival and symptoms in respiratory decline
  • Nutrition support and timely gastrostomy for dysphagia
  • Manage spasticity, cramps, drooling (sialorrhoea), communication aids, and provide early advance- care planning and palliative support

Disposition

Refer promptly to a neuromuscular/MND specialist service for diagnosis and coordinated care.

Complications & pitfalls

  • Respiratory failure (the usual cause of death), aspiration pneumonia, malnutrition, immobility complications, communication loss, and emotional/cognitive impact

Exam pearls

  • Mixed upper and lower motor neurone signs (brisk reflexes in a wasted, fasciculating limb) with completely normal sensation is the clinical fingerprint of MND — and respiratory function, not limb power, drives prognosis, so check the FVC early.
  • Monitoring & follow-up: Regular MDT review tracking respiratory function, weight/swallow, mobility and communication, with proactive intervention (NIV, gastrostomy). Psychological, carer and palliative support throughout; revisit advance decisions as the disease progresses.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.